Knight Therapeutics Price Target Raised at RBC, Raymond James
In This Article:
Analysts at RBC Capital Markets and Raymond James raised their price targets on Knight Therapeutics
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.